Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1

Abstract

These findings indicate that regorafenib induces a coordinated and reversible suppression of NO and stimulation of ET-1. Whether NO and ET-1 might predict therapeutic efficacy in these patients requires further study.